Bayer Pharma AG et al v. Dr. Reddy's Laboratories, Ltd. et al
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc. |
Dr. Reddys Laboratories, Ltd., Dr. Reddys Laboratories, Inc., Dr. Reddy's Laboratories Ltd. and Dr. Reddy's Laboratories Inc. |
1:2023cv00410 |
April 13, 2023 |
US District Court for the District of Delaware |
Richard G Andrews |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. ยง 271 Patent Infringement |
None |
Docket Report
This docket was last retrieved on May 17, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 9 WAIVER OF SERVICE returned executed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG: For Dr. Reddy's Laboratories Ltd. waiver sent on 5/16/2023, answer due 8/14/2023. (Fahnestock, Derek) |
Filing 8 WAIVER OF SERVICE returned executed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG: For Dr. Reddy's Laboratories Inc. waiver sent on 5/16/2023, answer due 8/14/2023. (Fahnestock, Derek) |
Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
Remark: MDL panel has been advised. (jfm) |
Filing 7 Summons Issued as to Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. on 4/13/2023. (Attachments: #1 Summons Issued Dr. Reddy's Laboratories, Ltd.)(jfm) (Main Document 7 replaced on 4/14/2023) (jfm). (Attachment 1 replaced on 4/14/2023) (jfm). |
Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (jfm) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Pharma AG filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (jfm) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,828,310 B2. (jfm) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/16/23. Date of Expiration of Patent: See Attached. Thirty Month Stay Deadline: Not Applicable. (jfm) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) |
Filing 1 COMPLAINT for PATENT INFRINGEMENT filed against Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. (Filing fee $ 402, receipt number ADEDC-4112327.) - filed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., and Bayer AG. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(jfm) (Main Document 1 replaced on 4/14/2023) (jfm). |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.